» Articles » PMID: 26029318

Sex Differences in the Excess Risk of Cardiovascular Diseases Associated with Type 2 Diabetes: Potential Explanations and Clinical Implications

Overview
Publisher Springer
Date 2015 Jun 2
PMID 26029318
Citations 72
Authors
Affiliations
Soon will be listed here.
Abstract

Strong evidence suggests that type 2 diabetes confers a stronger excess risk of cardiovascular diseases in women than in men; with women having a 27 % higher relative risk of stroke and a 44 % higher relative risk of coronary heart disease compared with men. The mechanisms that underpin these sex differences in the associations between diabetes and cardiovascular disease risk are not fully understood. Some of the excess risk may be the result of a sex disparity in the management and treatment of diabetes, to the detriment of women. However, accruing evidence suggests that real biological differences between men and women underpin the excess risk of diabetes-related cardiovascular risk in women such that there is a greater decline in risk factor status in women than in men in the transition from normoglycemia to overt diabetes. This greater risk factor decline appears to be associated with women having to put on more weight than men, and thus attain a higher body mass index, to develop diabetes. Further studies addressing the mechanisms responsible for sex differences in the excess risk of cardiovascular diseases associated with diabetes are needed to improve the prevention and management of diabetes in clinical practise.

Citing Articles

Exploring the gender difference in type 2 diabetes incidence in a Swiss cohort using latent class analysis: an intersectional approach.

Barbier J, Amiguet M, Vaucher J, Lasserre A, Clair C, Schwarz J BMJ Public Health. 2025; 2(1):e000472.

PMID: 40018095 PMC: 11812799. DOI: 10.1136/bmjph-2023-000472.


Sex differences in associations of metabolic inflammation and insulin resistance with incident type 2 diabetes mellitus: a retrospective cohort of adults with annual health examinations.

Li Y, Guo X, Ge J, Li Q, Chen X, Zhu Y Lipids Health Dis. 2025; 24(1):50.

PMID: 39953587 PMC: 11829553. DOI: 10.1186/s12944-025-02473-1.


Gender based difference in glycemic control and diabetes related chronic complications among type 2 diabetic patients in Debre Berhan city public hospitals.

Gebeyaw E, Lema G Metabol Open. 2025; 25:100349.

PMID: 39944659 PMC: 11816214. DOI: 10.1016/j.metop.2025.100349.


The Impact of Age and Sex on Fasting Plasma Glucose and Glycated Haemoglobin (HbA1c) in the Non-diabetes Population.

Stedman M, Heald A, Holland D, Halsall I, Green L, Wu P Diabetes Ther. 2024; 16(2):257-267.

PMID: 39704964 PMC: 11794718. DOI: 10.1007/s13300-024-01680-w.


First manifestation of cardiovascular disease according to age and sex in a Mediterranean country.

Ortega E, Genua I, Mata-Cases M, Roque M, Vlacho B, Real Gatius J Front Cardiovasc Med. 2024; 11:1403363.

PMID: 39355347 PMC: 11443696. DOI: 10.3389/fcvm.2024.1403363.


References
1.
Bertram M, Vos T . Quantifying the duration of pre-diabetes. Aust N Z J Public Health. 2010; 34(3):311-4. DOI: 10.1111/j.1753-6405.2010.00532.x. View

2.
Ryden L, Grant P, Anker S, Berne C, Cosentino F, Danchin N . ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD: the Task Force on diabetes, pre-diabetes, and cardiovascular diseases of the European Society of Cardiology (ESC) and developed in.... Eur Heart J. 2013; 34(39):3035-87. DOI: 10.1093/eurheartj/eht108. View

3.
Paul S, Thomas G, Majeed A, Khunti K, Klein K . Women develop type 2 diabetes at a higher body mass index than men. Diabetologia. 2012; 55(5):1556-7. DOI: 10.1007/s00125-012-2496-2. View

4.
Shah A, Langenberg C, Rapsomaniki E, Denaxas S, Pujades-Rodriguez M, Gale C . Type 2 diabetes and incidence of cardiovascular diseases: a cohort study in 1·9 million people. Lancet Diabetes Endocrinol. 2014; 3(2):105-13. PMC: 4303913. DOI: 10.1016/S2213-8587(14)70219-0. View

5.
Danaei G, Finucane M, Lu Y, Singh G, Cowan M, Paciorek C . National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2·7 million participants. Lancet. 2011; 378(9785):31-40. DOI: 10.1016/S0140-6736(11)60679-X. View